In this way, TLR2 signaling is strongly associated with the typical IBD mucosal damage, as TLR2 is able to modulate T-cell functions both directly, stimulating Th17 response [120], and indirectly, reducing the suppressive function of Tregs by promoting a shift toward IL-17 production [121]. Here, TLR2 is linked to inflammatory bowel disease.